Amantadine in Parkinson's disease.
P Millac, I Hasan, M L Espir, D G Slyfield
Abstract
Substances (1)
Related products
| Procduct Name | CAS | Molecular Formula | Supplier | Price |
| Amantadine | 768-94-5 | C10H17N | 504 suppliers | $7.00-$5445.00 |
Similar articles
IF:0
[Amantadine treatment in Parkinson's disease].
Nordisk medicin
K Boman, E Kivalo,etc
Published: 26 November 1970
IF:6.8
Amantadine in the treatment of Parkinson's disease and other movement disorders.
Journal of Medicinal Chemistry
Olivier Rascol, Margherita Fabbri,etc
Published: 1 December 2021
IF:3.5
Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease
Journal of Food Biochemistry
Ahsas Goyal, Aanchal Verma,etc
Published: 15 September 2022
Latest Papers
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.
Published: 24 March 2012
Dapoxetine treatment of premature ejaculation.
Published: 25 November 2006
Amantadine and pneumonia.
Published: 3 April 1999